Skip to Main Content

Paper Details

Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia.
Crit Care
2
2023
Author NameAffiliation
Antonio Artigas
Antonio ArtigasParcTauli Hospital Universitari, Institut d'Investigacio i Innovacio Parc Tauli (I3PT), Universitat Autonoma de Barcelona
Paolo PelosiSan Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences
Paolo PelosiUniversity of Genoa
  • 1 - 4

Datasets

Release 1.2